In metastatic TNBC, BRCA1 hypermethylation has been reported not to be associated with a better treatment response to carboplatin compared with docetaxel48 (although hypermethylation in this study was measured in the primary tumor tissue, not the actual metastatic tissue) or to single-agent carboplatin effect49. Here, BRCA1 is linked to neoplasm.